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A cell line (SCC-2S) derived from a human squamous cell 
ca rcin oma was found to have a higher level of in situ thy-
midyl ate synthase activity when compared to a faster-
g rowing ce ll line, L1210 leukemia , and approxim ately 5 
tim es the 1cvel of activity of a cell line with the sa me growth 
rate, S91-A m elanoma. T hese results led to an exa min ation 
o f the effects of both direct and indirect inhibitors of this 
enzy me using inta ct SCC- 2S cell s. It was fouild that dru gs 
that have an indirect effect on thi s enzy me--methotrexate 
(MTX), hyd roxyurea (HU), and 3,4-dih ydroxy benzyl-
amin e (3,4-DHBA)--acted as non co mpetitive inhibito rs 
and the inhibition of thymidylate synthase by these dru gs 
did not resul t in the accumulation of its substrate, dUMP . 
T his suggested that these dru gs are also inhibitin g steps 
lea din g to the fo rmation o f dUMP by a mechanism that 
---.. 
is coord inated with the inhibition of thymidylate sy nthast: 
f-F luorodeo x yuridine (FUDR) , a co mpetitive inhibitor ()\ 
thymidylate synthase, did ca use an in crease in the dUMtl 
poo l size indica ting that thi s dru g did not affect th e sYI(, 
thesis of this substrate . There w as a good correlation f() 
the inhibitio n of growth, DNA synthesis , and thymidylat; 
synthase with HU , 3,4-DI-lBA, and FUDR. However , th~ 
res ults sugges ted fundamentall y dIfferent mechanIstic rea, 
sons for the close relatiOl~ship among these three inhibitor). 
effects. Flllally the lIJhlbltlon. of growth by MTX did nOt 
appear to correl ate WIth th e lIlhlbltJon of DNA synthesis 
T he impli cation of these results for the th erapy of cpider~ 
ma lly derived proliferative diso rders , es peciall y with C0111, 
binatiolls s ll ch as MTX and 5-FU, is discussed. J II/ Vel l 
D em/(/(o/ 88:66-70, 1987 
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T h y mid ybte sy nth ase is the key enzy me in the de 11 0V.O synthesis of .dTTP and ex tensiv e efforts In ve been m ade to deve lo p dru gs that inhibit this stcp [1 ,2]. Two dru gs known to inhibit this enzy me are 5-Auo-rodeoxyuridill e (FU DR) w hich is phos phorylated to 
Fd U M P, an inhibito r o f th y midy late sy n thase; and m ethotrexate 
(MTX) w hi ch inhibits the form ;lti o n o f tetra h yd rofo late, the re-
du cin g substrate for thi s rea ctio n . These 2 dru gs ha ve been found 
to be effecti ve agents for th e treatment ofsq uam o ll s cell ca rcinoma 
(SeC) \3.41 as well as for th e treatment of a variety of nonma-
lig nant pro life ratin g diso rders of the keratinocy te, e.g .• pso riasis 
151. G iven th e app3rent utili ty of FUDR 3nd M TX in the t re3 t-
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dCyd: deoxycytidin c 
dUrd: dcoxyuridinc 
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HU : hyd roxyurea 
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m ent of these proliferating diseases of the epidermis, it woulq 
seem that thy midybte sy nthase might play a key role in th~ 
g rowth regulatio n and pe rh aps the patho phys iology of these e pi, 
dermal diseases. Importantl y, recent developments have ill1, 
proved th e culturin g methods for squ amous cell ca rcinoma [6,71 
so that their long-term senal cultivatio n Illay be conducted in th~ 
absence of a feeder layer. This techn o logy has made it possibl~ 
to do a variet y of biochemica l studies of the m echanis m of drug 
ac tion that would be mu ch 111 0re diffIcult to perform with ke, 
ratinocy tes supported by feeder layers and deri ved from different 
sources [8,9]. 
We have investi ga ted the inhibition of thymidylate sy nth ase by 
a variety of agents utili zed for clini ca l can cer th erap y [10]. This 
report describes stud ies th:\t were performed to examine the ill 
situ activity o f thi s enzyme in a cell line of human squamOLlS cell 
ca rcinoma. This includes an investiga tion of the effect of variOlls 
dru gs o n thymidylate synthase activ ity w ith respect to m echanism 
of action and th e rclati onship between the inhibition of this en-
zyme and the inhibition of DNA synthesis and g rowth. 
MATERlALS AND M ETHOD S 
Materials R adiolabeled [3HldTTP, r' H]thYlllidine, and 
[5-J H]deoxycytidine were purchased [rOI11 N ew E ng land Nu-
clear, Boston , M assachu setts. Radiolabcled f5-3 H]deoxyuridinr 
w as obta ined from Schwarz/ M ann , Cambrid ge, M assachusetts. 
Unlabeled nucleotides and nLlcleosides were obta in ed from P-L 
Biochemica ls, Milwaukee, Wisconsin . 3,4-Dih ydroxy benzyl_ 1 
am in e was prepared from the parent nitrile by cata lyti c hydro-
genation as described previously 1111. Hydro xyurea and 5-
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Auorodeoxy uri d ine we re obta ined from Sigma C hemi ca l Co., St. 
Louis, Misso uri. M ethotrexate was a g ift from Dr. A. Rosowsky, 
Dana- Farber Ca ncer Institu te, Boston, Massachusetts . 
Preparation and Propagation The procedure fo r the prepa-
ratio n and culturin g of sq uam ous cell carcinom a (SCC-25) , has 
been described [8 1· B riefl y, ce lls were g rown in D ulbecco's m od-
ified Eagle's m ed ium supplem ented w ith 10% feta l bov ine serum, 
penicillin (100 U / ml) , strepto m ycin (100 fLg / ml) , L-glutamin e (2 
111M), and hydrocortisone (0.4 fLg/ml). T he cel ls were checked 
for the presence of m ycop las m usi ng the rad io labelcd tech ni q ue 
described b y Schn eider et al 11 2]. 
In Situ Thymidylate Synthase Assays T he m ethod used to 
exa mine th ymidy late synth ase act ivity in situ is th e same pro-
cedure described by Ya lowich and Ka llll an 11 3 1. T his assay m ea-
sures the tritiu m released into the 1-1"0 phase fro m 15-3HldUMP 
w hich is fo rm ed in cells from [5-31-1]deoxy uridine by the action 
of th ymid yla te sy n thase . Ce lls arc subcu ltured in Linbro Illul ti-
well tissue culture trays fo r 48 h to estab li sh them in log phase 
of growth. T he g rowth m ed ium is asp irated and th e m ono la yer 
washed w ith fresh m edium. Se rum-free m ed ia (200 fLl) co nta ining 
(5-3H1UdR (0.66 fLCi, 5 fLM) was added to start ' th e reactio n. 
T hymid ylate synth ase activity was determi ned usin g the charcoa l 
fi ltrat io n m eth od described by Roberts [1 41. 
Cell Growth Expo nentially g rowin g cultures arc harvested and 
subcultures p lated in Linb ro multi well tissue culture trays . T he 
drug is add ed 24 h after plat in g and the ce lls are continu ously 
exposed to thi s sin g le dose for 48 h . T riplicate cultures are har-
vested and kerat in ocyte cells counted in J Model Z Coulter Counter. 
Macromolecular Assay T he techniqu e for radi o labelcd pre-
curso r incorporat ion has been descr ibed p rev io usly 11 5J. Cells are 
subcultured in Li nbro ll1ultiwell tissue cul ture trays fo r 48 h to 
es tablish th em in log phase of g rowth. T he g rowth medium is 
aspi rated and the m o no layer was hed w ith fres h m ed ium . Serum-
free m edi a (1.0 ml) con ta ining [3J-1] th ym idine o r 15-J I-l]dCyd is 
added alo ng with th e dru g. After I h at 37°C m ed ium is removed, 
cells washed once with sa line, and 0. 1 ml 10% TCA added. T he 
precipitate containing DNA is di ges ted fo r 4 h at 37°C and then 
prepared for scintil lJtion coun ting as previo usly described 11 5J. 
RES ULTS 
Preliminary studi es using the thymid ylate synthase in situ assay 
suggested that SCC-25 cells were releasing mo re tritium than an 
equ iva lent number of the faster-growing Ll 210 cells. A detailed 
study usin g the isotope dilution ana lysis [1 6, 17] to exam ine the 
relative in situ act ivity ofthym idylate synthase in severa l cc lliines 
is show n in Fig 1. T he slo pe of such a plot is a m easure of the 
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Figure 1. Isotope di lu tion ;lIlal ys is of thymidylatc synthasc acti vity in 
SCC-25 cel ls (-.-); Ll210 Icukemia cc lls (-A -) , and S9 1-A melanoma 
cells (-e -). 
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Figure 2. Hill type plot ofthc inhibition of th Ylllidinc in co rporation into 
SCC-25 cell s by hydroxyurea with (-0-) and without (-0 -) prein cu-
bation for I h. 
relative V",,, of th e rate-limi ting step leadi ng to the release of 
tr it ium w hich we have prev io usly shown in volves the cnzy m e 
thym id ylate sy nth Jse (submi tted for pu bli catio n). T he results in-
dicate that the in situ activity of thy mid y late sy nthase in SCC-
25 was considerably g reater than in the S9 1-A m elano ma cell line 
w hi ch has a very similar generatio n tim e. Furthermore, confi rm-
in g o ur initi al observJtions, the resul ts indi ca te that thy mi dy late 
synthase activity is g rea ter in SCC-25 than in L 1210 ce ll s w hi ch 
g row at almost twice the rate as the ep idermal ceJl line. 
This res ult suggested that thymid ylate syn thase mig ht playa 
m o re important ro le in contro llin g the rate of D N A synthes is in 
SCC-25 cells than in other types of cells. Two dru gs, FUDR and 
MTX, w hi ch arc kn own to have an effect o n th is enzy me arc 
also very effective in the treatment of tum ors derived from the 
epidermal cel l. Similarl y, h yd roxyurea (I-IU) has also been found 
to be useful in the treatment of sq uam ous cell ca rcin o m a. Fig ure 
2 shows the effect of prei ncub:ltion on the inhibition of D NA 
synth es is b y HU using a Hill type plot analysis /1 81. T he sIope 
of the lines o f such plots prov ides an indicatio n of the nu mber 
of m olecul es of dru g required to inactivate a criti ca l step lead ing 
to D N A synthesis [1 81. T he results indicate that fo ll owin g prein-
cubation the slo pe increases from approximatel y 2 to 4 w hi ch 
would suggest add itio nal steps arc bein g inactivated w ith longer 
exposure times and that the inhi b itory effects arc cum ul at ive . We 
have recently shown that this d ru g, w hi ch is known to directly 
inhibit ribonu cleotide redu ctase, ca n inhi bit th Yll1i dylate sy nthase 
in situ by an ind irect mechan ism that is t ime dependent. T his 
de layed inhibi tory effect o n thym id ylate sy nth ase m ay acco unt 
in pJ rt fo r the increJsin g effectiveness of H U in in hi bitin g DN A 
synth esis. This is consistent w ith the hypothesis that the inhibition 
of D N A sy nth esis by HU in volves a seq uenti al process that in-
clu des th e inactiva ti on of th ymi dy late sy nthase. 
In o rder to defin e the nature of the inhibi tion of thymid ylate 
synthase by these 3 drugs we performed a kinetic analys is to 
determine the effect of substrate concentratio n on inhibition . Fig-
ure 3a is a dou ble-reciproca l plot of the substrate concent rat ion 
vs velocity of the in situ reaction in the presence and absence of 
vario us dru gs . T he results indi cate that fo r 1-1 U and M TX the 
V",,, of the reaction is red uced in th e presence of these dru gs. 
T he K", fo r the reaction , however, is un changed , w hi ch sugges ts 
a noncompetitive type of inhibition. The double-reciproca l p lot 
in the presence of FUDR indicates a differen t type o f inhibitory 
mechanism w here the V",,, rema ins un affected but the va lue of 
the x-in tercept is decreased almost twofold. T his resul t is con-
sistent with a competitive inhibitor. 
Figure 31J is an isotope d ilu tion p lot of the sa me data. T he 
y-intercepts of these plots arc a m easure of the level of endogeno us 
co mpo und (dUMP) th at is competin g with the labeled substra te 
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at thc ra te-limi ting step 11 6], i.c. , thc rcaction catalyzed by thy-
midylate sy nth ase. T he results shown in Fig 3b indi cate that th e 
Ievcl of the endogeno us pool of dUM P is not af(ected by cither 
HU or MTX, but the size of the dUMP pool is increased in the 
p resence of FUDR . 
Fig ure 4 shows the dose-respo nse curves d ·termined by a Hill 
type plo t analysis for the inhibitio n of growth, D NA synthesis, 
and th ymid ylate synthase acti vity in SCC-25 ceJls using HU, 3,4-
DHBA, FU DH., and MTX. T he IC gu va lues, LogJV II - V)/v] 
= 0.0, for the three mctabolic paramcters are in fa irl y good 
agreement for FUDR . Thi ' is consistent w ith the notion that 
FUDR's cyto to xic effe ct is mediated b y the inh ibi tion of D NA 
synthesis d ue to the inhibition ofthYl11id ylate synthase by FdUMP, 
th e phospho ry lated deri va tive of FU DR. O ne interesting res ult 
fo un d w ith FUDR is that although the inhibitio n of thym idy late 
sy nthase W3S tota l, i.e . , a· lincar response 3t all doses, the inhibitio n 
of g rowth and D N A synthesis was o nl y partial. T hus the inhi-
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Figure 3. (/, A double-reciprocal plot ofvclocity (nnlOl 
of tri t ium rcleased/h/2 X 105 cell s) vs dUdr conCClh 
tration (P.M) in the presence of diffe rent inhibitors. 
T he standard in situ assay was used as described il\ 
Mat erials al/d M et/ lOris, except th at the alHount of colel 
dUdr W;IS va ried in the prest'llce of3 nM FUD I1 (- +-J: 
180 nM MTX (-.-); 100 P.M HU (-A - ), Or in thQ 
absence of drug (-e -). b, An iso tope dilution analysi\ 
of thymidybte syn thase activ ity in the p resence of 3 
nM FUDR (- + -); 180 nM MTX (-. -); 100 P.M H U 
(-£ -), o r in the absence of drug (-e -) . 
bition plateaus at approximately 25-30% of contro l at tb e hi ghes\ 
concentrations of the drug . 
The growth of SCC-25 was appro ximatel y 5 times m o re sen, 
siti ve to the effects of MTX th3n either DNA sy nthesis o r thy, 
lllid yb te synth ase activity, possibl y because MTX exerts other 
efFects bes ides the inhibition of DN A synthes is which ca n affect 
growth, i.e ., the inhibi tion o f RN A and protein sy nthesis ('t 9]. 
Sim il ar to the results observed w ith FUDR, we fo und that t110 
inhibition of D NA sy nth es is was o nl y p3rtial where3s inhibitiol\ 
of thymidy late sy nthase was complete. 
The dose-response curves fo r the inhibi tion of g rowth, DNA 
sy nth esis, and th ymid ylate sy nthasc by 3,4-DHBA and HU a r~ 
similar. We have previous ly shown that these 2 dru gs have ~ 
number ofsilllil ar features in terms o f their mechani sm of action, 
e.g., bo th d ru gs inhibit th e enzy me ribo nu cleotide redu ctase (20). 
Fig ure 4 indicates that for both drugs 311 3 curves are in clo e 
proximity, altho ug h as ca n be seen the dose-response curves for 
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DNA synthesis (-. - ); and th ymid y latc.: synth a~c activ-
ity (- A -) by FUDH, HU, M TX, and 3,4-DHJ3A . To 
determine the effects of FU D I1 and M TX o n DN A 
sy nthesis, incorpo ration of \' Hlc\Cyd was utilized' i 
w hereas wi th l-/U and 3,4-D H13A incorpo ratio n of 
I' H]dTTP was measured. 
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HU are much less steep than fo r 3,4-DHDA . For both of these 
drugs th e inhibi t io n o f DN A synthesis and g rowth was co mpl ete 
w hereas the inhibi t ion of th ymid ylate synthase was o nl y part ial. 
T his behav ior was the refo re th e re verse of the s ituat io n fo und 
with MTX and FUDr~. 
D ISC U SSIO N 
The find ings presented in this repo rt, w hi ch indi cate that the 
SCC-2S cc ll lin e has g reater th ymid ybte sy n thase ac ti v ity tlun 
other cell lin es that m ay be f.lster g rowin g, implies g reater uti-
lizatio n of th e de novo pathwa y for th e sy nthes is of dTTP . The 
reason for th is in creased act iv ity is uncl ear at this tim e. H owever, 
sin ce these cells a re slower g rowin g than the LI 210 leukemia ce lls 
that have lower th ym id ylate synthase activ ity, it see m s unlikel y 
tha t the SCC- 2S cells have a g rea ter demand fo r th e final product 
of th is pathway, i. e., dTTP. O ne possibility is that the SCC-2S 
cells have a red uced capacity to make dTTP using the sa lvage 
pathway and require in creased de novo sy nthes is . The res ults 
shown in Fi g 4 wo uld , however, suggest that the salv age path-
ways arc o perative in th is squam o us cell lin e, since alth o ugh 
thymid ylate synthase K tivi ty is co mpletel y inhibited, DNA sy n-
thesis and g rowth are onl y partiall y inhibited b y ·FUDn.. T he 
most likel y ex pl anatio n for this partial inhibition is that o nce 
thy mid y late sy nthasL: activity is tota ll y inhibited the sa lvage path-
ways produ ce eno ug h dTTP to m ai n tai n a redu ced level of DNA 
synthesis and g rowth . Alth o ug h the sa lvage pathway ap pea rs to 
be functi o na l, thL: increa sed th ymid y late sy nthase K tivity (w ith-
o ut a g reater demand fo r dTTP) implies a lower level act iv ity fo r 
the dTTP sa lvage pathway in the SCC- 2S cell lin e. The rL:ason 
for the hi g h leve l of de novo syn thesis ma y simpl y rest with the 
nature o f the in c reased thy mid ylate sy nth ase act ivity. T he 2 m os t 
li kely possibiliti es are an altered enzy m e w ith an in creased V"",x, 
o r an in creased am o unt of active no rm al enzy m e pe r cell. T hu s 
the g reate r utilization o f the pathwa y for de novo sy nthesis of 
dTTP m ay s impl y be due to g rea ter productio n o f thymid ybte 
synth ase (due to in creased acti v ity at the tran scriptional o r tra ns-
lationa l level) , o r a m o re effi cient enzy m L: . We are presentl y at-
temptin g to iso late thi s enzy m e fro m SCC-2S in o rde r to in ves-
ti gate these 2 poss ibilities. 
T he kineti c analys is o f the inhi bitio n of th ymid ybte sy n tha se 
by 3,4- 0 HDA and HU also revea led a po ten ti all y impo rtant re-
sult . B o th dru gs inhibit ribo nu cleotide red uctase 120], yet the 
isotope dilutio n analys is indi cated that these dru gs do no t affect 
the end ogeno us level o f dUMP. This resul t does no t necessa ril y 
mea n th at th ese drugs do not inhibit ribo nucl eotide red uctase o r 
specifi ca ll y the redu ction of UDP. T he inhibiti on of ribo nucle-
o tide reductase and thymidylate sy n thase by these dru gs could 
occur in a coo rdin ate fas hi o n , such that the decrease in dUMP 
produ ction b y th e inhibiti o n of ribonucleotid e red uctase wou ld 
be compensated fo r by a red ucti on in the use of this substrate by 
thymidylate syntluse, which is also being inhibited by these drugs. 
T he end result would be a stead y state in w hi ch the dUMP pool 
size wou ld rem ain at th e same level as in untre:Jted cell s . 
The isotope di luti o n anal ys is of the inhibiti on of th ymid y late 
synth ase by MTX sugges ted that the indirect inhibitio n of this 
enzy m e by M TX does no t result in an in crease in dUMP poo ls . 
M ethotrexa te is ap parentl y inhibiting the formation of d U M I' b y 
a m echanism that is coo rdinated w ith the inhibi tion of thymi-
dylate synthase . T his result is in contrast w ith the findin gs with 
FUDn., w hi ch inhibits th ymid ylate synthase, via its phos ph o r-
ylated interm ed iate FdUMP, in a co mpetiti ve m ann er, and w hi ch 
was found to in crease the pools of dUMP. This wou ld in di cate 
that FUO I1, unJike MTX , does not affect the fo rm ation of dUMP. 
The results of the study comparin g the dose res ponses fo r the 
in hibiti o n of g rowth, D NA syn thesis, and thym idybte synthase 
activity by the various d rugs (Fig 4) revea led several interes tin g 
fi ndin gs. Hyd roxyurea, 3, 4-DHBA , and FUOn gave ve ry similar 
responses for the 3 pa rameters in the IC so dose range and lower. 
Ho wever, an examination of the overJIl config uration of the curves 
revea ls several interes ting differences. Thus for HU and 3,4-0 HDA 
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the g rowth and D NA respo nses were si milar for the en tire range 
of doses and in d icated co mplete inhi b iti o n , w hereas th e curve fo r 
th e inhibitio n o f thymid ylate syn thase p lateaued , indicati ng par-
tia l inhibition. T his suggests that w hile the inhibitio n of th y mi-
d ylate sy nthase by these dru gs m ay contri b ute to th e in hibiti o n 
o f D N A sy nth es is and g rowth, th e primary effect must occur 
elsewhere , e. g. , inhi bit ion of ribonu cleotide reductase. O n the 
o ther hand, thi s result is consistent w ith the notion th at the in-
hibitio n of thy mid ylate synth 3se is no t a secondary effect of the 
inhibitio n of DNA synthesis. Con versely, th e results with FUOn 
show that the inhibitio n of th ymid ylate synthase is co mplete, 
w hereas the inh ibitio n of ON A syn thesis and g rowth is onl y 
pa rt ial. Th is m ay be the consequen ce of cells utilizin g the sa lvage 
pathwa y fo r dTTP synthesis and thus circum venting the b lock 
in de novo synthesis. Fin :! ll y, the res ults w ith MTX show that 
the relati onship between the inhibitio n of I NA synth es is and 
th y mid ylate sy nth ase are similar to th at fo un d w ith FUO n. , i. e. , 
partia l and complete inhibition, respecti vel y. However, the g rowth 
of SCC - 2S cell s see m s to be m o re sensiti ve to MTX. A possible 
ex planatio n is that MTX, in add it ion to inhibiting DNA syn-
thesi s, is known to affect both n.N A and pro tein synth esis 11 9 1. 
T hus the inhibiti o n of g rowth b y MTX m ay we ll be th e res ult 
of effects no t d irectl y related to D NA synthes is. 
It is appa rCilt frol1l these studies that thymidylate sy nth ase is 
an impo rtant con tro llin g en zy m e in epiderm all y derived ce lls. 
T he act ivity of this enzy m e ca n be affected b y a var iety of agen ts 
actin g throu g h either direct o r indirect inhibito ry m echanism s. 
Furthe rm o re, it appea rs that m any dru gs have mul t iple effects o n 
different D NA sy ntheti c CIl zy m es. While these secondary effects 
Ill:! y co n tribute to the ab ility of the dru g to inhibit cellular g rowth, 
they ma y 31so pose pro blem s fo r the develo pm ent of effecti ve 
co mbin atio n chem otherap y. T hus, it is essen tia l fo r th e ratio nal 
use o f d ru g co mbin ations to have a fu ll understand in g of all the 
inhibito ry effe cts that co ntribute to a dru g's cy totox icity. 
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